Intelligence · Clinical Pipeline
Sinovac Research and Pipeline
All ClinicalTrials.gov programs at Sinovac Research and — phase, modality, and trial IDs.
- Programs
- 18
Quick answer
Sinovac Research and has 18 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
100U EV71 vaccine with adjuvant
Sinovac Research and Development Co.,
Infection, Viral, Enterovirus
1 trial -
400 U EV71 vaccine with adjuvant
Sinovac Research and Development Co.,
Infection, Viral, Enterovirus
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)
Sinovac Research and Development Co.,
COVID-19
1 trial -
COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain
Sinovac Research and Development Co.,
COVID-19
1 trial -
CoronaVac®
Sinovac Research and Development Co.,
COVID-19
1 trial -
Low-dose experimental vaccine
Sinovac Research and Development Co.,
Herpes Zoster
1 trial -
Low-dose of tetravalent inactivated enterovirus vaccine (Vero cell)
Sinovac Research and Development Co.,
Hand, Foot, and Mouth Disease (HFMD)
1 trial -
Medium-dose COVID-19 Vaccine(Vero Cell),Inactivated
Sinovac Research and Development Co.,
COVID-19
1 trial -
Oral hexavalent reassortant rotavirus attenuated live vaccine
Sinovac Research and Development Co.,
Rotavirus Gastroenteritis
2 trials -
SA55 Injection
Sinovac Research and Development Co.,
Infection of Upper Respiratory Tract Caused by 2019-nCoV
1 trial -
SNA02-48
Sinovac Research and Development Co.,
Tetanus
1 trial -
Single-dose regimen of high dosage investigational sIPV
Sinovac Research and Development Co.,
Poliomyelitis
1 trial -
Sinovac Low-dosage PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
1 trial -
Sinovac PCV24
Sinovac Research and Development Co.,
Pneumococcal Infectious Disease
2 trials -
Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28
Sinovac Research and Development Co.,
COVID-19
1 trial -
Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28
Sinovac Research and Development Co.,
COVID-19
2 trials -
low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated
Sinovac Research and Development Co.,
Hand, Foot and Mouth Disease
1 trial -
pandemic influenza vaccine (H5N1 strain NIBRG-14)
Sinovac Research and Development Co.,
Pandemic Influenza
1 trial
Frequently asked questions
How many pipeline programs does Sinovac Research and have?
18 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs